Stockreport

Eli Lilly slips as obesity scripts said to trail those for Novo's Wegovy [Seeking Alpha]

Novo Nordisk A/S  (NVO) 
Last novo nordisk a/s earnings: 2/5 01:31 am Check Earnings Report
US:NYSE Investor Relations: novonordisk.com/investors.html
PDF weight loss therapies, Foundayo and Zepbound, trailed those for Novo Nordisk's ( NVO ) rival drug, Wegovy, according to IQVIA ( IQV ) data sourced by analysts. Cantor [Read more]